Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BDMD NASDAQ:CTSO NASDAQ:MDAI NYSE:RBOT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDMDBaird Medical Investment$1.91-6.4%$4.02$1.05▼$12.50$13.43M-0.99178,530 shs345,200 shsCTSOCytosorbents$0.87+2.3%$1.04$0.71▼$1.61$54.42M1.1964,449 shs4.61 million shsMDAISpectral AI$2.36-4.8%$2.29$0.82▼$3.25$62.79M0.9620,951 shs401,881 shsRBOTVicarious Surgical$8.69-1.9%$8.51$4.27▼$19.00$52.54M1.4134,307 shs22,756 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDMDBaird Medical Investment-6.37%-6.37%-51.40%-64.70%+190,999,900.00%CTSOCytosorbents+2.26%-7.88%-13.08%-7.53%-27.57%MDAISpectral AI-4.84%-9.23%-6.72%+85.83%+41.32%RBOTVicarious Surgical-0.57%-23.04%+17.75%+3.17%+20.19%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/AN/AN/ACTSOCytosorbents1.1921 of 5 stars3.32.00.00.00.00.00.6MDAISpectral AI2.2838 of 5 stars3.72.00.00.01.13.30.0RBOTVicarious Surgical0.8869 of 5 stars1.04.00.00.00.62.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBDMDBaird Medical Investment 0.00N/AN/AN/ACTSOCytosorbents 2.50Moderate Buy$5.50532.77% UpsideMDAISpectral AI 3.33Buy$4.75101.27% UpsideRBOTVicarious Surgical 2.00Hold$8.50-2.19% DownsideCurrent Analyst Ratings BreakdownLatest BDMD, CTSO, RBOT, and MDAI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/21/2025CTSOCytosorbentsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.006/25/2025CTSOCytosorbentsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.005/15/2025CTSOCytosorbentsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00 ➝ $10.005/15/2025CTSOCytosorbentsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$1.00 ➝ $1.005/2/2025CTSOCytosorbentsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00 ➝ $10.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/ACTSOCytosorbents$35.33M1.54N/AN/A$0.20 per share4.35MDAISpectral AI$29.58M2.02N/AN/A($0.32) per share-7.38RBOTVicarious SurgicalN/AN/AN/AN/A$7.89 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBDMDBaird Medical InvestmentN/AN/A0.00∞N/AN/AN/AN/AN/ACTSOCytosorbents-$20.72M-$0.28N/AN/AN/A-41.77%-105.04%-29.18%8/7/2025 (Estimated)MDAISpectral AI-$15.31M-$0.54N/AN/AN/A-30.75%N/A-11.37%N/ARBOTVicarious Surgical-$63.22M-$10.45N/AN/AN/AN/A-120.53%-85.51%8/12/2025 (Estimated)Latest BDMD, CTSO, RBOT, and MDAI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025RBOTVicarious Surgical-$2.61N/AN/AN/AN/AN/A8/7/2025Q2 2025CTSOCytosorbents-$0.07N/AN/AN/A$9.79 millionN/A5/14/2025Q1 2025CTSOCytosorbents-$0.08-$0.06+$0.02-$0.02$9.01 million$8.73 million5/12/2025Q1 2025RBOTVicarious Surgical-$2.61-$2.58+$0.03-$2.60N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBDMDBaird Medical InvestmentN/AN/AN/AN/AN/ACTSOCytosorbentsN/AN/AN/AN/AN/AMDAISpectral AIN/AN/AN/AN/AN/ARBOTVicarious SurgicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBDMDBaird Medical InvestmentN/AN/AN/ACTSOCytosorbents0.982.612.30MDAISpectral AIN/A1.411.37RBOTVicarious SurgicalN/A5.055.05Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBDMDBaird Medical Investment19.78%CTSOCytosorbents32.87%MDAISpectral AI67.08%RBOTVicarious Surgical47.27%Insider OwnershipCompanyInsider OwnershipBDMDBaird Medical Investment78.90%CTSOCytosorbents7.30%MDAISpectral AI30.70%RBOTVicarious Surgical11.99%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBDMDBaird Medical InvestmentN/A6.58 million1.39 millionN/ACTSOCytosorbents22062.61 million58.04 millionOptionableMDAISpectral AI8325.32 million17.55 millionNot OptionableRBOTVicarious Surgical2105.93 million5.22 millionNo DataBDMD, CTSO, RBOT, and MDAI HeadlinesRecent News About These CompaniesVicarious Surgical names Stephen From as next CEOAugust 2 at 9:47 AM | medtechdive.comMVicarious Surgical Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, Appointed Chief Executive OfficerJuly 31 at 7:16 PM | finance.yahoo.comVicarious Surgical has a new CEOJuly 31 at 7:16 PM | massdevice.comVicarious Surgical to Report Second Quarter 2025 Financial Results on August 12, 2025July 29, 2025 | businesswire.comDDD Partners LLC Purchases 28,357 Shares of Vicarious Surgical Inc. (NYSE:RBOT)July 16, 2025 | marketbeat.comVicarious Surgical Inc. (RBOT) - Yahoo FinanceJuly 4, 2025 | finance.yahoo.comVicarious Surgical Announces Election of New DirectorsJune 30, 2025 | businesswire.comHere's Why We're A Bit Worried About Vicarious Surgical's (NYSE:RBOT) Cash Burn SituationJune 18, 2025 | finance.yahoo.comGlucotrack, Inc. Appoints Dr. Victoria E. Carr-Brendel to Board of DirectorsMay 28, 2025 | quiverquant.comQVicarious Surgical Inc (RBOT) Q1 2025 Earnings Call Highlights: Strategic Partnerships and ...May 13, 2025 | gurufocus.comQ1 2025 Vicarious Surgical Inc Earnings Call TranscriptMay 12, 2025 | gurufocus.comVicarious Surgical inks surgical robot collab with hospital, eyes first clinical patientsMay 12, 2025 | massdevice.comVicarious Surgical Inc. (RBOT) Q1 2025 Earnings Call TranscriptMay 12, 2025 | seekingalpha.comVicarious Surgical Announces New Collaboration with UMass Memorial Medical CenterMay 12, 2025 | gurufocus.comVicarious Surgical Reports First Quarter 2025 Financial ResultsMay 12, 2025 | gurufocus.comVicarious Surgical Reports First Quarter 2025 Financial ResultsMay 12, 2025 | businesswire.comVicarious Surgical Announces New Collaboration with UMass Memorial Medical CenterMay 12, 2025 | businesswire.comWhy Vicarious Surgical Inc.’s (RBOT) Stock Is Up 11.04%April 29, 2025 | aaii.comAIntuitive wins FDA clearance for single-port robotic surgery staplerApril 11, 2025 | medtechdive.comMVicarious Surgical Receives Continued Listing Standard Notice from the NYSEApril 11, 2025 | gurufocus.comVicarious Surgical Receives Continued Listing Standard Notice from the NYSEApril 11, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBDMD, CTSO, RBOT, and MDAI Company DescriptionsBaird Medical Investment NASDAQ:BDMD$1.91 -0.13 (-6.37%) As of 08/1/2025 04:00 PM EasternBaird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.Cytosorbents NASDAQ:CTSO$0.87 +0.02 (+2.26%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.84 -0.03 (-3.47%) As of 08/1/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.Spectral AI NASDAQ:MDAI$2.36 -0.12 (-4.84%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$2.33 -0.03 (-1.48%) As of 08/1/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.Vicarious Surgical NYSE:RBOT$8.69 -0.17 (-1.92%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$8.75 +0.06 (+0.69%) As of 08/1/2025 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale Is PG&E an AI Power Play? Why Options Traders Are Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
